Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D005260:Female; D007111:Immunity, Cellular / Q000187:drug effects*; D051379:Mice; D009374:Neoplasms, Experimental / Q000276:immunology*; D013154:Spleen / Q000187:drug effects / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology; D013997:Time Factors
D000970:Antineoplastic Agents